Страна: США
мова: англійська
Джерело: NLM (National Library of Medicine)
ceftizoxime sodium (UNII: 26337D5X88) (ceftizoxime - UNII:C43C467DPE)
Fujisawa Healthcare, Inc.
ceftizoxime sodium
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
500 mg
INTRAMUSCULAR
PRESCRIPTION DRUG
Cefizox (ceftizoxime for injection, USP) is indicated in the treatment of infections due to susceptible strains of the microorganisms listed below. Lower Respiratory Tract Infections caused by Klebsiella spp.; Proteus mirabilis ; Escherichia coli; Haemophilus influenzae including ampicillinresistant strains; Staphylococcus aureus (penicillinase and nonpenicillinaseproducing); Serratia spp.; Enterobacter spp.; Bacteroides spp.; and Streptococcus spp. including S. pneumoniae , but excluding enterococci. Urinary Tract Infections caused by Staphylococcus aureus (penicillinase and nonpenicillinaseproducing); Escherichia coli ; Pseudomonas spp. including P. aeruginosa ; Proteus mirabilis ; P. vulgaris ; Providencia rettgeri (formerly Proteus rettgeri ) and Morganella morganii (formerly Proteus morganii ); Klebsiella spp.; Serratia spp. including S. marcescens ; and Enterobacter spp. Gonorrhea including uncomplicated cervical and urethral gonorrhea caused by Neisseria gonorrhoeae . Pelvic Inflamma
Cefizox® (ceftizoxime for injection, USP) NDC 0469725001 Product No. 725001 Equivalent to 500 mg ceftizoxime in 10 mL, singledose, fliptop vials, individually packaged NDC 0469725101 Product No. 725101 Equivalent to 1 gram ceftizoxime in 20 mL, singledose, fliptop vials, individually packaged NDC 0469725201 Product No. 725201 Equivalent to 1 gram ceftizoxime in 100 mL, singledose, Piggyback, fliptop vials, packaged in tens NDC 0469725302 Product No. 725302 Equivalent to 2 grams ceftizoxime in 20 mL, singledose, fliptop vials, individually packaged NDC 0469725402 Product No. 725402 Equivalent to 2 grams ceftizoxime in 100 mL, singledose, Piggyback, fliptop vials, packaged in tens Unreconstituted Cefizox should be protected from excessive light, and stored at controlled room temperature (59º86ºF) in the original package until used. Rx only
CEFIZOX- CEFTIZOXIME SODIUM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION FUJISAWA HEALTHCARE, INC. ---------- CEFIZOX (CEFTIZOXIME FOR INJECTION, USP) FUJIS AWA To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefizox and other antibacterial drugs, Cefizox should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. _FOR INTRAMUSCULAR_ _OR INTRAVENOUS USE_ DES CRIPTION Cefizox (ceftizoxime for injection, USP) is a sterile, semisynthetic, broadspectrum, betalactamase resistant cephalosporin antibiotic for parenteral (IV, IM) administration. It is the sodium salt of [6R- [6a,7β(Z)]]7[[(2,3dihydro2imino4 thiazolyl) (methoxyimino) acetyl] amino]8oxo5thia1azabicyclo [4.2.0] oct2ene2carboxylic acid. Its sodium content is approximately 60 mg (2.6 mEq) per gram of ceftizoxime activity. It has the following structural formula: C H N NAO S 4 05.38 Ceftizoxime for injection, USP is a white to pale yellow crystalline powder. Cefizox is supplied in vials equivalent to 500 mg, 1 gram or 2 grams of ceftizoxime, and in Piggyback Vials for IV admixture equivalent to 1 gram or 2 grams of ceftizoxime. CLINICAL PHARMACOLOGY The table below demonstrates the serum levels and duration of Cefizox (ceftizoxime for injection, USP) following IM administration of 500 mg and 1 gram doses, respectively, to normal volunteers. SERUM CONCENTRATIONS AFTER INTRAMUSCULAR ADMINISTRATION SERUM CONCENTRATION (ΜG/ML) Dose ½ hr 1 hr 2 hr 4 hr 6 hr 8hr 500 mg 13.3 13.7 9.2 4.8 1.9 0.7 1 gm 36.0 39.0 31.0 15.0 6.0 3.0 Following IV administration of 1, 2, and 3 gram doses of Cefizox to normal volunteers, the following serum levels were obtained. ® ® 12 12 5 5 2 SERUM CONCENTRATIONS AFTER INTRAVENOUS ADMINISTRATION SERUM CONCENTRATION (ΜG/ML) * Dose 5 min 10 min 30 min 1 hr 2 hr 4 hr 8 hr 1 gram ND ND 60.5 38.9 21.5 8.4 1.4 2 grams 131.8 110.9 77.5 53.6 33.1 12.1 2.0 3 grams 221.1 174.0 112.7 83.9 47.4 26.2 4.8 A serum halflife of approximately 1.7 hours was ob Прочитайте повний документ